Drugs / IVIEW-1201
last change Aug 2026 re-read 2 minutes ago

IVIEW-1201

Developed for
fungal keratitis
Investigated by
IVIEW Therapeutics Inc.

Trials 1 · a red edge is where a trial was stopped

20272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06463678 Aug 2026 → Dec 2027 expected fungal keratitis IVIEW Therapeutics Inc. Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IVIEW-1201 ClinicalTrials.gov intervention name — accepted as the source's own label NCT06463678
Route Other “administer 1 drop into the conjunctival sac” NCT06463678